Endoplasmic Reticulum Stress in Subepithelial Myofibroblasts Increases the TGF-β1 Activity That Regulates Fibrosis in Crohn's Disease.


Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 15 10 2019
pubmed: 8 2 2020
medline: 13 7 2021
entrez: 8 2 2020
Statut: ppublish

Résumé

Endoplasmic reticulum (ER) stress is an essential response of epithelial and immune cells to inflammation in Crohn's disease. The presence and mechanisms that might regulate the ER stress response in subepithelial myofibroblasts (SEMFs) and its role in the development of fibrosis in patients with Crohn's disease have not been examined. Subepithelial myofibroblasts were isolated from the affected ileum and normal ileum of patients with each Montreal phenotype of Crohn's disease and from normal ileum in non-Crohn's subjects. Binding of GRP78 to latent TGF-β1 and its subcellular trafficking was examined using proximity ligation-hybridization assay (PLA). The effects of XBP1 and ATF6 on TGF-β1 expression were measured using DNA-ChIP and luciferase reporter assay. Endoplasmic reticulum stress components, TGF-β1, and collagen levels were analyzed in SEMF transfected with siRNA-mediated knockdown of DNMT1 and GRP78 or with DNMT1 inhibitor 5-Azacytidine or with overexpression of miR-199a-5p. In SEMF of strictured ileum from patients with B2 Crohn's disease, expression of ER stress sensors increased significantly. Tunicamycin elicited time-dependent increase in GRP78 protein levels, direct interaction with latent TGF-β1, and activated TGF-β1 signaling. The TGFB1 DNA-binding activity of ATF-6α and XBP1 were significantly increased and elicited increased TGFB1 transcription in SEMF-isolated from affected ileum. The levels of ER stress components, TGF-β1, and collagen expression in SEMF were significantly decreased following knockdown of DNMT1 or GRP78 by 5-Azacytidine treatment or overexpression of miR-199a-5p. Endoplasmic reticulum stress is present in SEMF of patients susceptible to fibrostenotic Crohn's disease and can contribute to development of fibrosis. Targeting ER stress may represent a novel therapeutic target to prevent fibrosis in patients with fibrostenotic Crohn's disease.

Sections du résumé

BACKGROUND
Endoplasmic reticulum (ER) stress is an essential response of epithelial and immune cells to inflammation in Crohn's disease. The presence and mechanisms that might regulate the ER stress response in subepithelial myofibroblasts (SEMFs) and its role in the development of fibrosis in patients with Crohn's disease have not been examined.
METHODS
Subepithelial myofibroblasts were isolated from the affected ileum and normal ileum of patients with each Montreal phenotype of Crohn's disease and from normal ileum in non-Crohn's subjects. Binding of GRP78 to latent TGF-β1 and its subcellular trafficking was examined using proximity ligation-hybridization assay (PLA). The effects of XBP1 and ATF6 on TGF-β1 expression were measured using DNA-ChIP and luciferase reporter assay. Endoplasmic reticulum stress components, TGF-β1, and collagen levels were analyzed in SEMF transfected with siRNA-mediated knockdown of DNMT1 and GRP78 or with DNMT1 inhibitor 5-Azacytidine or with overexpression of miR-199a-5p.
RESULTS
In SEMF of strictured ileum from patients with B2 Crohn's disease, expression of ER stress sensors increased significantly. Tunicamycin elicited time-dependent increase in GRP78 protein levels, direct interaction with latent TGF-β1, and activated TGF-β1 signaling. The TGFB1 DNA-binding activity of ATF-6α and XBP1 were significantly increased and elicited increased TGFB1 transcription in SEMF-isolated from affected ileum. The levels of ER stress components, TGF-β1, and collagen expression in SEMF were significantly decreased following knockdown of DNMT1 or GRP78 by 5-Azacytidine treatment or overexpression of miR-199a-5p.
CONCLUSIONS
Endoplasmic reticulum stress is present in SEMF of patients susceptible to fibrostenotic Crohn's disease and can contribute to development of fibrosis. Targeting ER stress may represent a novel therapeutic target to prevent fibrosis in patients with fibrostenotic Crohn's disease.

Identifiants

pubmed: 32031621
pii: 5729993
doi: 10.1093/ibd/izaa015
pmc: PMC7324000
doi:

Substances chimiques

Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
Transforming Growth Factor beta1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

809-819

Subventions

Organisme : NIDDK NIH HHS
ID : R29 DK049691
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK015564
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000058
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK049691
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK049691
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK028300
Pays : United States

Informations de copyright

© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Pathol. 2016 Nov;186(11):2921-2933
pubmed: 27662798
Inflamm Bowel Dis. 2014 Jul;20(7):1250-8
pubmed: 24831560
J Crohns Colitis. 2013 May;7(4):286-300
pubmed: 22578910
Inflamm Bowel Dis. 2017 Dec 19;24(1):159-165
pubmed: 29272478
Inflamm Bowel Dis. 2016 Apr;22(4):984-93
pubmed: 26950312
Gastroenterology. 2007 Jan;132(1):190-207
pubmed: 17241871
Am J Physiol. 1998 Aug;275(2):G342-51
pubmed: 9688662
Epigenetics. 2014 Jan;9(1):119-28
pubmed: 23959088
Cell Death Dis. 2013 Apr 18;4:e604
pubmed: 23598416
Oncol Lett. 2018 Nov;16(5):6531-6539
pubmed: 30405792
Inflamm Bowel Dis. 2019 Mar 14;25(4):661-671
pubmed: 30590697
Gut. 2015 Mar;64(3):504-17
pubmed: 25475103
United European Gastroenterol J. 2016 Aug;4(4):496-505
pubmed: 27536359
Epigenetics. 2012 Sep;7(9):987-93
pubmed: 22894907
J Biol Chem. 2009 Apr 24;284(17):11326-35
pubmed: 19251704
Inflamm Bowel Dis. 2013 Dec;19(13):2829-39
pubmed: 24051933
Nucleic Acids Res. 2000 Apr 15;28(8):E32
pubmed: 10734209
J Biochem. 2004 Sep;136(3):343-50
pubmed: 15598891
PLoS One. 2012;7(2):e31518
pubmed: 22359598
J Vis Exp. 2013 Oct 12;(80):
pubmed: 24145735
Gut. 2013 Jul;62(7):1072-84
pubmed: 23626373
Fibrogenesis Tissue Repair. 2015 Oct 01;8:18
pubmed: 26435749
Gastroenterology. 2013 May;144(5):989-1000.e6
pubmed: 23336977
Am J Respir Crit Care Med. 2014 Feb 1;189(3):263-73
pubmed: 24299514
Gastroenterology. 1997 Sep;113(3):817-24
pubmed: 9287973
Exp Cell Res. 2011 Nov 15;317(19):2772-9
pubmed: 21821022
Genet Mol Res. 2014 Apr 14;13(2):2727-38
pubmed: 24782087
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
Cell. 2008 Sep 5;134(5):743-56
pubmed: 18775308
Inflamm Bowel Dis. 2015 Mar;21(3):636-44
pubmed: 25581827
Nat Rev Mol Cell Biol. 2010 Apr;11(4):252-63
pubmed: 20216554
J Immunol. 2010 Sep 15;185(6):3529-35
pubmed: 20720212
Am J Physiol. 1999 Aug;277(2):C183-201
pubmed: 10444394
Inflamm Bowel Dis. 2016 Jan;22(1):241-7
pubmed: 26588089
J Biol Chem. 2010 May 14;285(20):15065-75
pubmed: 20208072
Inflamm Bowel Dis. 2018 Sep 15;24(10):2224-2241
pubmed: 29860326
Inflamm Bowel Dis. 2014 Sep;20(9):1638-54
pubmed: 24896241
Trends Pharmacol Sci. 2012 Jul;33(7):382-93
pubmed: 22613783
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
Gastroenterology. 2010 Jan;138(1):285-93
pubmed: 19751734
Gastroenterology. 2017 Feb;152(2):340-350.e6
pubmed: 27720839

Auteurs

Chao Li (C)

Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.

John R Grider (JR)

VCU Program for Enteric Neurosciences, Virginia Commonwealth University, Richmond, VA, USA.
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.

Karnam S Murthy (KS)

VCU Program for Enteric Neurosciences, Virginia Commonwealth University, Richmond, VA, USA.
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.

Jaime Bohl (J)

Department of surgery, Division of Colon and Rectal surgery, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.

Emily Rivet (E)

Department of surgery, Division of Colon and Rectal surgery, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.

Nicole Wieghard (N)

Department of surgery, Division of Colon and Rectal surgery, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.

John F Kuemmerle (JF)

VCU Program for Enteric Neurosciences, Virginia Commonwealth University, Richmond, VA, USA.
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH